Fluorine in Pharmaceuticals: Looking Beyond Intuition

Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents. Organofluorine affects nearly all physical and adsorption, distribution, metabolism, and excretion properties of a lead compound. Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines. In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on molecular conformation of the drug, has only recently begun. Here, we review experimental progress in this vein and add complementary analysis based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.

[1]  F. Leroux.  Atropisomerism, Biphenyls, and Fluorine: A Comparison of Rotational Barriers and Twist Angles , 2004, Chembiochem : a European journal of chemical biology.

[2]  J. Hernández‐Trujillo,et al.  Molecular Quadrupole Moments for the Series of Fluoro- and Chlorobenzenes , 1996 .

[3]  M. Wilson,et al.  Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus. , 1990, Journal of medicinal chemistry.

[4]  Justin C. Biffinger,et al.  The Polar Hydrophobicity of Fluorinated Compounds , 2004, Chembiochem : a European journal of chemical biology.

[5]  T. Maren,et al.  A new class of carbonic anhydrase inhibitor. , 1993, The Journal of biological chemistry.

[6]  Martin Stahl,et al.  Fluorine in Medicinal Chemistry , 2004, Chembiochem : a European journal of chemical biology.

[7]  M. Schlosser.  CF(3)-bearing aromatic and heterocyclic building blocks. , 2006, Angewandte Chemie.

[8]  J. Matsumoto,et al.  1,4-Dihydro-4-oxopyridinecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent , 1984 .

[9]  Alex Avdeef,et al.  Physicochemical Profiling (Solubility, Permeability and Charge State) , 2001 .

[10]  Manfred Kansy,et al.  Fluorine Interactions at the Thrombin Active Site: Protein Backbone Fragments HCαCO Comprise a Favorable CF Environment and Interactions of CF with Electrophiles , 2004, Chembiochem : a European journal of chemical biology.

[11]  E. LaVoie,et al.  Bioisosterism: A Rational Approach in Drug Design. , 1996, Chemical reviews.

[12]  B. Roth,et al.  The discovery and development of atorvastatin, a potent novel hypolipidemic agent. , 2002, Progress in medicinal chemistry.

[13]  W. R. Dolbier,et al.  Fluorine chemistry at the millennium , 2005 .

[14]  K. Kirk,et al.  Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules , 2006 .

[15]  A. Pike,et al.  Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles. , 1999, Journal of medicinal chemistry.

[16]  Paul Seiler,et al.  A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions. , 2003, Angewandte Chemie.

[17]  D. Christianson,et al.  Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II. , 2001, Journal of the American Chemical Society.

[18]  E. Goldsmith,et al.  Structural basis of inhibitor selectivity in MAP kinases. , 1998, Structure.

[19]  D. O'Hagan,et al.  Fluorine in medicinal chemistry: A review of anti-cancer agents , 2006 .

[20]  D. Bonnet-Delpon,et al.  Recent advances (1995–2005) in fluorinated pharmaceuticals based on natural products ☆ , 2006 .

[21]  B. Fermini,et al.  The impact of drug-induced QT interval prolongation on drug discovery and development , 2003, Nature Reviews Drug Discovery.

[22]  Y. Shimohigashi,et al.  Edge-to-face CH/pi interaction between ligand Phe-phenyl and receptor aromatic group in the thrombin receptor activation. , 2000, Journal of biochemistry.

[23]  N. Kitteringham,et al.  Metabolism of fluorine-containing drugs. , 2001, Annual review of pharmacology and toxicology.

[24]  W. Middleton.  New fluorinating reagents. Dialkylaminosulfur fluorides , 1975 .

[25]  K. Drlica,et al.  Fluoroquinolones: action and resistance. , 2003, Current topics in medicinal chemistry.

[26]  Chu-Young Kim,et al.  Contribution of Fluorine to Protein−Ligand Affinity in the Binding of Fluoroaromatic Inhibitors to Carbonic Anhydrase II , 2000 .

[27]  D. Wong,et al.  Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. , 1995, Life sciences.

[28]  D W Banner,et al.  Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes. , 1997, Chemistry & biology.

[29]  Bruce E. Smart,et al.  Fluorine substituent effects (on bioactivity) , 2001 .

[30]  G. Whitesides,et al.  Thermodynamic parameters for the association of fluorinated benzenesulfonamides with bovine carbonic anhydrase II. , 2007, Chemistry, an Asian journal.

[31]  B. Langlois,et al.  Trifluoroacetamides from amino alcohols as nucleophilic trifluoromethylating reagents. , 2003, Angewandte Chemie.

[32]  Z. Rankovic,et al.  Medicinal chemistry of hERG optimizations: Highlights and hang-ups. , 2006, Journal of medicinal chemistry.

[33]  M. Malet‐Martino,et al.  Interest of Fluorine-19 Nuclear Magnetic Resonance Spectroscopy in the Detection, Identification and Quantification of Metabolites of Anticancer and Antifungal Fluoropyrimidine Drugs in Human Biofluids , 2006, Chemotherapy.

[34]  Manfred Kansy,et al.  Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities , 2007, ChemMedChem.

[35]  D. D. Perrin,et al.  pKa prediction for organic acids and bases , 1981 .

[36]  F. Diederich,et al.  A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions. , 2004, Organic & biomolecular chemistry.

[37]  M. Schlosser,et al.  Alpha-fluorinated ethers, thioethers, and amines: anomerically biased species. , 2005, Chemical reviews.

[38]  François Diederich,et al.  Orthogonal multipolar interactions in structural chemistry and biology. , 2005, Angewandte Chemie.

[39]  F. Diederich,et al.  Interactions with aromatic rings in chemical and biological recognition. , 2003, Angewandte Chemie.

[40]  D. Bundschuh,et al.  Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. , 2006, Pulmonary pharmacology & therapeutics.

[41]  Dongsung Lim,et al.  Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic. , 2003, Bioorganic & medicinal chemistry.

[42]  M. Bols,et al.  Stereoelectronic substituent effects in polyhydroxylated piperidines and hexahydropyridazines. , 2002, Chemistry.

[43]  F. Diederich,et al.  Mapping the Fluorophilicity of a Hydrophobic Pocket: Synthesis and Biological Evaluation of Tricyclic Thrombin Inhibitors Directing Fluorinated Alkyl Groups into the P Pocket , 2006, ChemMedChem.

[44]  J. Snyder,et al.  The Unexpected Diaxial Orientation of cis-3,5-Difluoropiperidine in Water: A Potent CF- - -NH Charge-Dipole Effect , 2000 .

[45]  F. Diederich,et al.  A weak attractive interaction between organic fluorine and an amide group. , 2004, Angewandte Chemie.

[46]  C. Moyes,et al.  3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. , 2001, Journal of medicinal chemistry.

[47]  Robin Taylor,et al.  Organic Fluorine Hardly Ever Accepts Hydrogen Bonds , 1997 .

[48]  Manfred Kansy,et al.  A Fluorine Scan at the Catalytic Center of Thrombin: CF, COH, and COMe Bioisosterism and Fluorine Effects on pKa and log D Values , 2006, ChemMedChem.

[49]  G. Pez,et al.  BIS(2-METHOXYETHYL)AMINOSULFUR TRIFLUORIDE : A NEW BROAD-SPECTRUM DEOXOFLUORINATING AGENT WITH ENHANCED THERMAL STABILITY , 1999 .

[50]  Jun‐An Ma,et al.  Asymmetric fluorination, trifluoromethylation, and perfluoroalkylation reactions. , 2004, Chemical reviews.

[51]  E. Pinard,et al.  Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability. , 2006, Bioorganic & medicinal chemistry letters.

[52]  J. Dunitz,et al.  Molecular pair analysis: C-H...F interactions in the crystal structure of fluorobenzene? And related matters. , 2006, Chemistry.

[53]  Manfred Kansy,et al.  Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors. , 2006, Organic & biomolecular chemistry.

[54]  J. Snyder,et al.  3-Fluoropiperidines and N-methyl-3-fluoropiperidinium salts: the persistence of axial fluorine. , 2005, Chemistry.